On-Demand Webinar | YPrime and Clinical Supply Consulting
While delays in eCOA and IRT go-lives are often attributed to technology, pressure tends to build during User Acceptance Testing (UAT), where execution becomes more complex and time-sensitive.
Watch this on-demand 30-minute webinar to see how sponsors are rethinking UAT, not as a late-stage checkbox, but as a critical control point that directly impacts speed, quality, and trial integrity.
Why UAT Has Become a Critical Risk Point
As trial complexity increases and timelines compress, UAT is happening under more pressure than ever. It’s often introduced late, with limited time for iteration, and carries significant regulatory expectations. When issues surface at this stage, the result is rework, delays, and increased risk to study startup.
In this session, YPrime and Clinical Supply Consulting walk through how one sponsor responded when their IRT go-live timeline was unexpectedly accelerated by two months.
With traditional timelines no longer viable, the team took a different approach—executing a focused, risk-based UAT in a single day. Importantly, this was done without compromising audit readiness or introducing downstream risk.
Key Takeways and Tips On How You Can Improve Clinical Technology UAT
This session offers a grounded perspective on how to improve UAT execution in real-world conditions. Gain insight into:
- Why UAT consistently becomes a bottleneck in eCOA and IRT implementations
- How regulators and inspectors evaluate UAT readiness and documentation
- When an accelerated UAT approach is appropriate—and when it introduces risk
- How to structure UAT to support both speed and compliance
If you are responsible for trial startup, system implementation, or operational delivery, this session is directly relevant. It’s designed for Clinical Operations, Clinical Supply and IRT, and eCOA or Digital Trial leaders focused on execution, system readiness, and data quality.
FAQs
User Acceptance Testing (UAT) validates that systems like IRT and eCOA function correctly before go-live. It ensures workflows, configurations, and data capture align with protocol requirements and regulatory expectations.
UAT delays occur when testing is compressed into late timelines, increasing the likelihood of errors and rework. Without a structured, risk-based approach, issues discovered during UAT can delay study startup and site activation.
When designed as a risk-based process, UAT focuses on high-impact scenarios, reduces unnecessary cycles, and improves execution efficiency—allowing teams to move faster without sacrificing quality or compliance.
Take the Next Step to Improve Your eClinical UAT
If UAT is a constraint in your current or upcoming trials, there’s an opportunity to rethink how it’s structured.
Connect with our team to discuss your next study, visit www.yprime.com/demo.
Check Out What Our Experts Have to Say
about trial design, data capture, operational efficiencies, and, ultimately, how to solve with certainty in clinical research.
